← Back to Search

Coronary Artery Stent

Interventional for Coronary Artery Disease (PAS Trial)

N/A

Waitlist Available

Led By Joel Schnieder, MD

Research Sponsored by Tryton Medical, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 year

Awards & highlights

PAS Trial Summary

This trial will assess the safety and efficacy of the Tryton Side Branch Stent in patients with bifurcation coronary artery disease.

PAS Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Target Vessel Failure (TVF)

Secondary outcome measures

CD-TLR

CD-TVR

Death

+5 more

PAS Trial Design

1Treatment groups

Experimental Treatment

Group I: InterventionalExperimental Treatment1 Intervention

Coronary artery stenting of De novo bifurcation lesions MB & SB

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Coronary Artery Stenting

2005

N/A

~1600

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Tryton Medical, Inc.Lead Sponsor

2 Previous Clinical Trials

233 Total Patients Enrolled

1 Trials studying Coronary Artery Disease

133 Patients Enrolled for Coronary Artery Disease

Joel Schnieder, MDPrincipal InvestigatorRex Health; Raleigh NC

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities for enrolment in this clinical trial currently?

"Affirmative. Per clinicaltrials.gov, the trial posted on January 22nd 2018 is actively recruiting participants with a target of 335 patients across 1 medical centre. It was last updated February 22nd 2019."

Answered by AI

What is the cap on enrolment for this medical trial?

"Affirmative. The clinical trial's page on clinicaltrials.gov indicates that it is currently looking for 335 individuals to take part in the study from 1 site. This medical research was posted online on January 22nd 2018, with its most recent update occurring February 22nd 2019."

Answered by AI

Is the cut-off for participation in this trial restricted to individuals aged 70 and below?

"This trial is seeking participants that are over the age of majority but less than 90 years old."

Answered by AI

What qualifications must an individual possess in order to take part in this trial?

"This medical experiment is looking for 335 patients suffering from coronary artery disease that are between 18 and 90 years of age. To qualify, the individual must meet several conditions including being a suitable candidate for CABG surgery, possessing informed consent documentation approved by the relevant Institutional Review Board (IRB), having a de novo lesion in bifurcation with visual diameter stenosis ≥ 50%, and agreeing to comply with follow-up evaluations. Furthermore, certain requirements pertaining to native coronary arteries and FDA approved drug-eluting stents (DES) will apply."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Tryton Post Approval Study (PAS) for the Tryton Side Branch Stent

2018. "Tryton Post Approval Study (PAS) for the Tryton Side Branch Stent". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03318796.